Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/VAXART-INC-40834288/news/Vaxart-Announces-Last-Subject-Dosed-in-Phase-1-Trial-of-Its-Norovirus-Vaccine-Candidate-in-Lactating-45617386/?utm_source=whatsapp&utm_medium=social&utm_campaign=share